Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet Closes Private Financing Round

NEW YORK (GenomeWeb) – Scottish microarray instrument maker Arrayjet today announced that it has closed a £650,000 ($867,773) private investment round.

Archangel Investors led the round, with additional investment from Scottish Enterprise.

Arrayjet said it would use the funds from the financing to expand its in-house consultancy service Arrayjet Advance, broaden its global footprint, and bring new products to market.

"This latest round of investment … will help Arrayjet capitalize on the global market demand for our technology, and accelerate the company's pace of product innovation," Arrayjet CEO Iain McWilliam said in a statement.

Last year, the company announced a contract with CDI Laboratories valued at more than $600,000. The year before, it signed a co-development agreement with Safeguard for food safety arrays.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.